Nesrin GÖKHAN, Göknur AKTAY, Hakkı ERDOĞAN

Synthesis of some new pyridylethylated benzoxa [Thia]zolinones with analgesic activity

Eighteen new 3-[2-(2-/4-pyridyl)ethyl]benzoxazolinone(benzothiazolinone) derivatives were synthesized by reacting 2-/4-vinylpyrJdine and appropriate benzoxazolinones and benzothiazolinones. The analgesic activities of these compounds were investigated by modified Koster and hot-plate tests. Test results revealed that most of the compounds at 100 mg/kg dose levels have higher analgesic activities than acetylsalicylic acid. Compounds with bromo substituents on the phenyl ring in the 6-position of the main ring seemed to show less activity than those with fluorinated ones. Compound 6b showed remarkably high activity in the hot-plate test, although it was inactive in the Koster test. However compound 3a had statistically significant high peripheral analgesic activity at all doses compared to other compounds, although it was inactive in the hot-plate test.

PDF

___

1. H. Erdoğan, M. Debaertand J.C.Cazin, Arzneim.-Forsch./Drug Res. 41, 73-76 (1991).
2. E. Palaska, S. Ünlü, H. Erdoğan, C. Şafak, B. Gümüşel and R. Demirdamar, Eur. J. Med. Chem. 28, 963-967 (1993).
3. N. Gökhan, H. Erdoğan, N.T. Durlu and R. Demirdamar, Eur. J. Med. Chem. 31, 625-628 (1996).
4. N. Gökhan, H. Erdoğan, N.T. Durlu and R.Demirdamar, Archiv der Pharmazie Pharm. and Medicinal Chem. 332, 43-50 (1999).
5. E. Palaska, N. Gökhan, H. Erdoğan, B.C. Tel and R.Demirdamar, Arzneim.-Forsch./Drug Res. 49, 754-758 (1999).
6. W.J. Close, B.D. Tiffany and M.A. Spielman, J. Am. Chem. Soc. 71, 1265, (1949).
7. C. Flouzat, Y. Besson, A. Mattio, J. Bonnet and G. Guillaumet, J. Med. Chem. 36, 497-503 (1993).
8. D. Lesieur, C. Lespagnol and S.Yous, Eur. Patent No. 395 526 (1990). (Chem. Abstr. 114 164208x, 1991).
9. Fujisawa Pharmaceutical Co. Ltd., Jpn. Kokai Tokkyo Koho JP 5 953 475 [8453475] (1984) (Chem Abstr. 101 90983d, 1984).
10. S.H. Ferreira, B.B. Lorenzotti, M. Devissaguet, D. Lesieur and Y.Tsouderos, Br. J. Pharmacol. 114, 303-308 (1995).
11. T. Takashima, Y. Kadoh, S. Kumada, T. Takashima, Y. Kadoh and S. Kumada, Arzneim.-Forsch./Drug Res. 22, 711-715 (1992).
12. K. Tsurumi, Y. Hiramatsu, M. Nozaki, M. Hayashi and H. Fujimura, Arzneim.-Forsch./Drug Res. 22, 716-724 (1972).
13. G. Pilli, H. Erdoğan and R. Sunal, Arzneim.-Forsch./Drug Res. 43, 12-15 (1993).
14. A. Temizer, N. Özaltın and H. Erdoğan, Port. Electroc. Acta 5, 33-41 (1987).
15. O.I. Petrov, A.T. Antonova, V.B. Kalcheva and C.G. Veleva, Dokl. Bulg. Akad. Nauk. 47, 31-34 (1994).
16. H. Uçar, K. Van Derpoorten, P. Depovere, D. Lesieur, M. Isa, B. Masereel, J. Delarge and J. H. Poupaert, Tetrahedron 54, 1763-1772 (1998).
17. S.L. Shapiro, I.M. Rose and L. Freedman, L, J. Am. Chem. Soc. 79, 2811-2814 (1957).
18. R. Koster and M. Anderson, Fed. Proc. 18, 412 (1959).
19. J.H. Rosland, S. Hunskaar, O.J. Broch and K. Hole,.Pharmacol. Toxicol. 70, 31-37 (1992).
20. J.P. Bonte, D. Lesieur, C. Lespagnol and J.C. Cazin, Eur. J. Med. Chem.-Chim. Ther. 9, 491-498 (1974).
21. H. Aichaoui, J.H. Poupaert, D. Lesieur and J.P. H´enichart, Tetrahedron 47, 6649-6654 (1991).
22. N. Gökhan, H. Erdoğan, N.T. Durlu and R. Demirdamar, Il Farmaco 54, 112-115 (1999).
23. P.G. Mairesse, J.C. Boivin, D.J. Thomas, M.C. Bermann, J.P. Bonte and D. Lesieur, Acta Cryst. C40, 1019-1020 (1984).